Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Multiple sclerosis: Bigger brains resist disability in MS.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
A rare case of SPG11 mutation with multiple sclerosis.
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Translational challenge models in support of efficacy studies: Neurobehavioral and cognitive changes induced by Transcranial Magnetic Stimulation in healthy volunteers.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.
Clinical utility and psychometric properties of the Functional Assessment of Multiple Sclerosis for individuals with multiple sclerosis.

Pages